Insulin Glargine (U-100) Vials and Lomitapide Mesylate
Determining the interaction of Insulin Glargine (U-100) Vials and Lomitapide Mesylate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
Generic Name: lomitapide
Brand name: Juxtapid
Synonyms: Lomitapide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin Glargine (U-100) Vials-Lomocot
- Insulin Glargine (U-100) Vials-Lomotil
- Insulin Glargine (U-100) Vials-Lomotil (Diphenoxylate and Atropine Solution)
- Insulin Glargine (U-100) Vials-Lomotil (Diphenoxylate and Atropine Tablets)
- Insulin Glargine (U-100) Vials-Lomustine
- Insulin Glargine (U-100) Vials-Long Lasting Nasal Spray
- Lomitapide Mesylate-Insulin Glargine (U-300) Pens
- Lomitapide Mesylate-Insulin glargine and lixisenatide
- Lomitapide Mesylate-Insulin glargine and lixisenatide Subcutaneous
- Lomitapide Mesylate-Insulin glargine, recombinant Subcutaneous
- Lomitapide Mesylate-Insulin glulisine
- Lomitapide Mesylate-Insulin Glulisine (Cartridges and Pens)